NCT06103682View on ClinicalTrials.gov

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

December 5, 2025

Study Completion Date

January 5, 2031

Conditions
Non-small Cell Lung CancerOligoprogressiveSmall-cell Lung Cancer
Interventions
DEVICE

Ablative local therapy

Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy

Trial Locations (1)

95817

RECRUITING

University of California, Davis, Sacramento

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, Davis

OTHER